Efficiency of Double Layered Microencapsulated Probiotic to Modulate ProInflammatory Molecular Markers for the Management of Alcoholic Liver Disease

Table 3

Growth of microencapsulated L. plantarum (log₁₀ cfu) in Simulated Gastric fluid (SGF) and Simulated Intestinal fluid (SIF) (𝑛=6).

	Simulated gastric fluid				Simulated intestinal fluid
Time	0 hr	1 hr	2 hr	4 hr	5 hr	6 hr	%
Unencapsulated probiotic	8.76±0.11	8.06±0.14	7.79±0.11	7.38±0.2	6.73±0.22	4.25±0.31	56.8%
AL beads	8.59±0.39	8.14±0.23	7.5±0.43	7.2±0.38	6.26±0.34	5.97±0.09^a	69.4%
AL-CA beads	8.81±0.12	8.4±0.37	8.02±0.16	7.52±0.42	6.41±0.41	6.29±0.13^b,c	71%

Beads at the end of 4 hours were shifted to SIF. All values are represented as mean ± standard deviation. ^a𝑃<0.05 versus unencapsulated probiotic; ^b𝑃<0.05 versus AL beads; ^c𝑃<0.05 versus AL beads.